Home/Pipeline/Autism Program

Autism Program

Autism Spectrum Disorder

DiscoveryActive

Key Facts

Indication

Autism Spectrum Disorder

Phase

Discovery

Status

Active

Company

Ignite Biomedical

About Ignite Biomedical

Ignite Biomedical is a private, pre-revenue biotech company pioneering an AI-driven approach to precision medicine. Its core technology is a quantitative AI platform used to de-risk and accelerate the discovery of mRNA-based diagnostics and precision drug targets, with active programs in immunology, autism, PTSD, and substance use disorder. The company's value proposition centers on drastically reducing diagnostic delays, improving treatment efficacy prediction, and condensing pre-clinical drug development timelines to 1-2 years. Its mission is to fulfill the broken promises of precision medicine by delivering pragmatic, patient-focused solutions.

View full company profile

Therapeutic Areas

Immunology Autism Spectrum Disorder Post-Traumatic Stress Disorder (PTSD)Substance Use Disorder (SUD)

Other Autism Spectrum Disorder Drugs

Drug	Company	Phase	Status
NTI164	Neurotech International	Phase 3	Active
Exo‑Autism	Advancells	Phase 1	Active
Kingdom Therapeutics Collaboration	Celadon Pharmaceuticals	Pre-clinical	Active
MDXX‑2	PharmAla Biotech	Preclinical	Active
NeuroNOS-1	NeuroNOS	Preclinical	Active
Banked Cord Blood Stem Cells	Cryo-Cell	Clinical Trials	Investigational